NPC, gastric carcinoma, HL, and natural killer cell lymphoma are grouped into the type 2 latency cancers with their characteristic expression of EBNA1, LMP1, LMP2, and BARF1, which are intermediately immunogenic. This evidence concerns the gene PSMB9 and Hodgkins lymphoma.